Tribunal allows CENVAT credit use during suspension, following Noble Drugs Ltd. precedent. The Tribunal ruled in favor of the appellant, allowing them to use the CENVAT credit account for duty payment during the suspended period. The decision ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tribunal allows CENVAT credit use during suspension, following Noble Drugs Ltd. precedent.
The Tribunal ruled in favor of the appellant, allowing them to use the CENVAT credit account for duty payment during the suspended period. The decision aligned with the precedent set by Noble Drugs Ltd., exempting the appellant from facing interest and penalties. The impugned order was set aside, and the appeal was allowed, providing consequential relief to the appellant and deeming the show-cause notice unnecessary.
Issues involved: Appeal against confirmed interest and penalty for utilization of CENVAT credit during suspension of duty payment facility.
Analysis: 1. Facts of the Case: The appellant, a manufacturer of excisable goods, faced confirmed interest and penalty for utilizing CENVAT credit during the suspension period of their duty payment facility.
2. Legal Issue: The main issue was whether the appellant could use the CENVAT credit account for duty payment during the suspended period in 2001-02.
3. Precedent: The Tribunal referred to the case of Noble Drugs Ltd. (2007) where it was held that before 31.03.2005, during the facility's suspension, the assessee could utilize the CENVAT credit account without facing interest and penalty.
4. Decision: The Tribunal ruled in favor of the appellant, stating that they were entitled to use the CENVAT credit account for duty payment during the suspended period. The Tribunal found the issue settled in favor of the appellant based on the precedent set by Noble Drugs Ltd.
5. Judgment: Consequently, the impugned order was set aside, and the appeal was allowed with consequential relief for the appellant, as the show-cause notice was deemed unnecessary based on the Tribunal's decision.
6. Conclusion: The judgment provided clarity on the utilization of CENVAT credit during the suspension period, aligning with the precedent set by Noble Drugs Ltd., and ultimately favored the appellant by allowing them to use the credit account for duty payment without facing additional interest and penalties.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
